Citigroup Lifts Ventas (VTR) Price Target to $96, Reiterates Buy Rating

Citigroup has adjusted its outlook on Ventas (VTR), a prominent healthcare real estate investment trust, by raising its price target. The financial giant increased the target to $96 per share, up from the previous $88. Concurrently, Citigroup reiterated its "Buy" rating for Ventas stock, signaling continued confidence in the company's prospects. This upward revision reflects the analyst's positive assessment of Ventas's performance and future potential within the healthcare sector. Such a move from a major institution typically indicates a bullish sentiment, potentially attracting increased investor interest in VTR shares. The consistent "Buy" recommendation underscores a strong belief in the stock's ability to deliver returns.